First In Human Study of the Doraya Catheter for the Treatment of AHF Patients
NCT03234647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2021-05-06
Summary
Safety and performance evaluation of the Doraya catheter in patients admitted with AHF.
Conditions
- Acute Heart Failure
Interventions
- DEVICE
-
Doraya catheter
Temporary deployment of the Doraya catheter in AHF patients.
Sponsors & Collaborators
-
Revamp Medical Ltd.
lead INDUSTRY
Principal Investigators
-
Tal Hasin, MD · Shaare Zedek Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- Belgium
- Israel
- Poland
Study Locations
More Related Trials
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
NCT02157506 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
NCT01067859 ·Status: TERMINATED ·Phase: PHASE2
-
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
NCT03036124 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
NCT03387215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents
NCT04703751 ·Status: UNKNOWN ·Phase: NA
-
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
NCT01064037 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
NCT01464476 ·Status: TERMINATED ·Phase: PHASE3
-
REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis
NCT06788535 ·Status: COMPLETED ·Phase: PHASE3
-
DUTCH Weight Control in Atrial Fibrillation Study
NCT06184633 ·Status: RECRUITING ·Phase: PHASE4
-
Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
NCT00849108 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.
NCT00219388 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
NCT00353522 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
NCT06062966 ·Status: RECRUITING ·Phase: PHASE1
-
CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices
NCT03217331 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
NCT05532046 ·Status: TERMINATED ·Phase: PHASE1
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
NCT05677100 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Dapagliflozin on Recurrence After Catheter Ablation for Atrial Fibrillation
NCT06433479 ·Status: COMPLETED ·Phase: NA
-
The Metabolic Road to Diastolic Heart Failure: Diastolic Heart Failure Study
NCT02446327 ·Status: COMPLETED ·Phase: NA
-
Peroral Levosimendan in Chronic Heart Failure
NCT00130884 ·Status: COMPLETED ·Phase: PHASE2
-
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868 ·Status: UNKNOWN ·Phase: PHASE4
-
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
NCT00401687 ·Status: COMPLETED ·Phase: PHASE4
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction
NCT04840914 ·Status: COMPLETED ·Phase: PHASE1